S. Liauw

发表

Hematologic Nadirs During Chemoradiation for Anal Cancer: Temporal Characterization and Dosimetric Predictors.

C. Pelizzari, D. Golden, D. Chang, 2017, International journal of radiation oncology, biology, physics.

EXTERNAL BEAM RADIATION THERAPY TREATMENT PLANNING FOR CLINICALLY LOCALIZED PROSTATE CANCER on Radiation Oncology–Prostate:

A. D'Amico, G. Gustafson, G. Ezzell, 2016 .

ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II

A. D'Amico, G. Gustafson, G. Ezzell, 2016, Advances in radiation oncology.

The use of capecitabine in the combined-modality therapy for rectal cancer.

B. Minsky, S. Liauw, 2008, Clinical colorectal cancer.

Radiotherapy after subtotally resected or recurrent ganglioglioma.

W. Mendenhall, R. Amdur, S. Liauw, 2007, International journal of radiation oncology, biology, physics.

Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity.

C. Pelizzari, S. Liauw, A. Pederson, 2012, International journal of radiation oncology, biology, physics.

Utilizing the TrueBeam Advanced Imaging Package to monitor intrafraction motion with periodic kV imaging and automatic marker detection during VMAT prostate treatments

G. Redler, S. Liauw, M. Korpics, 2020, Journal of applied clinical medical physics.

Dose‐escalated radiation therapy for intermediate‐risk prostate cancer

R. Weichselbaum, A. Jani, S. Liauw, 2009, Cancer.

Optimizing the Role of Surgery and Radiation Therapy in Urethral Cancer Based on Histology and Disease Extent.

S. Liauw, A. Solanki, Y. Hasan, 2018, International journal of radiation oncology, biology, physics.

Age and Grade Trends in Prostate Cancer (1974–2003): A Surveillance, Epidemiology, and End Results Registry Analysis

V. Master, O. Brawley, P. Johnstone, 2008, American journal of clinical oncology.

High-risk Prostate Cancer Treated With Dose-escalated RT: An Analysis of Hormonal Therapy Use and Duration, and Prognostic Implications of PSA Nadir ⩽0.2 to Select Men for Short-term Hormonal Therapy

F. Feng, D. Hamstra, S. Liauw, 2017, American journal of clinical oncology.

Randomized trials and new directions in gastrointestinal cancer.

T. Brunner, J. Cheng, Jeffrey Meyer, 2015, International journal of radiation oncology, biology, physics.

Gastrointestinal Cancers: Timing Is Everything.

James D. Murphy, D. Chang, S. Apisarnthanarax, 2017, International journal of radiation oncology, biology, physics.

Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy

D. Chang, S. Liauw, A. Solanki, 2013, OncoTargets and therapy.

Combined Modality Therapy for Rectal Cancer: The Relative Value of Posttreatment Versus Pretreatment CEA as a Prognostic Marker for Disease Recurrence

Julian C. Hong, A. Koong, D. Chang, 2012, Annals of Surgical Oncology.

Gastrointestinal Cancers-Changing the Standard for Rectal Cancer and Establishing a New Standard for Liver Tumors.

James D. Murphy, D. Chang, S. Apisarnthanarax, 2016, International journal of radiation oncology, biology, physics.

Grade migration in prostate cancer: an analysis using the Surveillance, Epidemiology, and End Results registry

V. Master, P. Johnstone, P. Rossi, 2007, Prostate Cancer and Prostatic Diseases.

Salvage radiotherapy for biochemical failure of radical prostatectomy: a single-institution experience.

C. Roehrborn, S. Liauw, D. Pistenmaa, 2003, Urology.

Key New Studies in Gastric and Esophageal Cancer.

T. Brunner, J. Cheng, Jeffrey Meyer, 2015, International journal of radiation oncology, biology, physics.

Pretreatment multiparametric MRI is independently associated with biochemical outcome in men treated with radiation therapy for prostate cancer.

A. Oto, S. Liauw, P. Patel, 2018, Urologic oncology.

Endorectal MRI for risk classification of localized prostate cancer: Radiographic findings and influence on treatment decisions.

A. Oto, R. Dess, S. Liauw, 2016, Urologic oncology.

A Prostate Fossa Contouring Instructional Module: Implementation and Evaluation.

C. Fuller, Seungtaek L. Choi, D. Golden, 2016, Journal of the American College of Radiology : JACR.

Salvage radiotherapy after postprostatectomy biochemical failure: does pretreatment radioimmunoscintigraphy help select patients with locally confined disease?

R. Weichselbaum, A. Jani, S. Liauw, 2008, International journal of radiation oncology, biology, physics.

The Role of Indium-111 Radioimmunoscintigraphy in Post-Radical Retropubic Prostatectomy Management of Prostate Cancer Patients

A. Jani, S. Liauw, M. Blend, 2007, Clinical Medicine & Research.

Reply to H.W. Daniell and to L. Azoulay and S. Suissa

R. Weichselbaum, T. Karrison, S. Liauw, 2010 .

Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels

R. Weichselbaum, K. Roggin, H. Kindler, 2022, Annals of Surgical Oncology.

Biochemical Control and Toxicity after Intensity-Modulated Radiation Therapy for Prostate Cancer

C. Pelizzari, H. Al-Hallaq, R. Weichselbaum, 2009, Technology in cancer research & treatment.

Oncology scan-novel treatment strategies for gastrointestinal cancers.

T. Brunner, J. Cheng, Jeffrey Meyer, 2014, International journal of radiation oncology, biology, physics.

Creation of a Novel Digital Rectal Examination Evaluation Instrument to Teach and Assess Prostate Examination Proficiency.

Karen M. Schmidt, T. Showalter, H. Cathro, 2017, Journal of surgical education.

Prostate-specific antigen halving time while on neoadjuvant androgen deprivation therapy is associated with biochemical control in men treated with radiation therapy for localized prostate cancer.

R. Malik, A. Jani, S. Liauw, 2011, International journal of radiation oncology, biology, physics.

"…during metastasis, platelets surround cancer cells in the bloodstream, which protects them from immune surveillance and promotes their colonization at distant sites."

K. Choe, S. Liauw, 2013 .

Effects of aspirin on cancer initiation and progression

K. Choe, S. Liauw, 2013, Expert review of anticancer therapy.

Circulating tumor-tissue modified HPV DNA analysis for molecular disease monitoring after chemoradiation for anal squamous cell carcinoma: a case report.

B. Shogan, S. Liauw, Benjamin D. Shogan, 2021, Journal of gastrointestinal oncology.

The use of anticoagulants improves biochemical control of localized prostate cancer treated with radiotherapy

K. Choe, A. Jani, S. Liauw, 2009, Cancer.

Prostate Cancer Radiotherapy: Increased Biochemical Control and Late Toxicity in Men With Medication Allergies

M. Spiotto, S. Liauw, S. Gutiontov, 2020, JNCI cancer spectrum.

Late toxicity and quality of life after definitive treatment of prostate cancer: redefining optimal rectal sparing constraints for intensity-modulated radiation therapy

C. Pelizzari, S. Liauw, S. Chennupati, 2014, Cancer medicine.

A prospective clinical and transcriptomic feasibility study of oral‐only hormonal therapy with radiation for unfavorable prostate cancer in men 70 years of age and older or with comorbidity

T. Antic, D. Golden, T. Karrison, 2021, Cancer.

High-dose radiotherapy with or without androgen deprivation therapy for intermediate-risk prostate cancer: cancer control and toxicity outcomes.

P. Rossi, A. Jani, S. Liauw, 2012, International journal of radiation oncology, biology, physics.

Blood prostate-specific antigen by volume of benign, Gleason pattern 3 and 4 prostate tissue.

M. Cooperberg, A. Vickers, B. Helfand, 2022, Urology.

Herpes zoster and radiation therapy: what radiation oncologists need to know about diagnosing, preventing, and treating herpes zoster.

M. Macomber, S. Liauw, K. Mullane, 2014, Practical radiation oncology.

Hematuria following Post-Prostatectomy Radiotherapy: Incidence Increases with Long-Term Followup

S. Eggener, J. Dignam, S. Liauw, 2022, The Journal of urology.

Lymph node‐positive head and neck cancer treated with definitive radiotherapy

W. Mendenhall, D. Villaret, R. Amdur, 2008, Cancer.

Definitive radiotherapy for head-and-neck cancer with radiographically positive retropharyngeal nodes: incomplete radiographic response does not necessarily indicate failure.

W. Mendenhall, R. Amdur, S. Liauw, 2006, International journal of radiation oncology, biology, physics.

PI-RADS score is associated with biochemical control and distant metastasis in men with intermediate-risk and high-risk prostate cancer treated with radiation therapy.

A. Oto, S. Liauw, P. Patel, 2020, Urologic oncology.

Prostate Cancer Update 2022

W. Catalona, S. Liauw, S. Loeb, 2022 .

Intra-operative Radiation Therapy for Colorectal or Anal Cancer at Risk for Margin-Positive Resection: Initial Results of a Single-Institution Registry

H. Al-Hallaq, S. Liauw, B. Polite, 2022, Annals of Surgical Oncology.

Prostate Cancer Outcomes Following Solid-Organ Transplantation: A SEER-Medicare Analysis.

R. Weichselbaum, Y. Becker, S. Eggener, 2019, Journal of the National Cancer Institute.

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.

Richard K Valicenti, Jeff M Michalski, Michael W Kattan, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prostate Cancer Modality Time Trend Analyses From 1973 to 2004: A Surveillance, Epidemiology, and End Results Registry Analysis

V. Master, P. Johnstone, P. Rossi, 2009, American journal of clinical oncology.

Management of Low-Stage Testicular Seminoma.

S. Eggener, S. Liauw, S. Pearce, 2015, The Urologic clinics of North America.

Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline.

E. Bass, B. Leibovich, P. Pierorazio, 2019, The Journal of urology.

Statin use and risk of prostate cancer recurrence in men treated with radiation therapy.

R. Weichselbaum, T. Karrison, S. Liauw, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial

Hao Wang, P. Tran, J. Hearn, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ACR Appropriateness Criteria Renal Cell Carcinoma Staging.

M. Blaufox, R. Vikram, S. Raman, 2016, Journal of the American College of Radiology : JACR.

Multidisciplinary Management and Radiotherapy Recommendations for Clinically and Pathologically Node-positive Bladder Cancer.

J. Efstathiou, M. Rouprêt, A. Choudhury, 2023, Seminars in radiation oncology.

Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials?

R. Weichselbaum, S. Liauw, R. Gutt, 2009, Nature Clinical Practice Gastroenterology &Hepatology.

Stereotactic Body Radiotherapy for the Treatment of Oligometastatic Renal Cell Carcinoma

R. Weichselbaum, W. Stadler, D. Golden, 2013, American journal of clinical oncology.

Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy.

Shree Agrawal, Daniel A Hamstra, Jeff M Michalski, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.

E. B. Butler, M. Kattan, C. Roehrborn, 2004, JAMA.

Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational Study.

M. Kattan, A. Zietman, M. Anscher, 2016, International journal of radiation oncology, biology, physics.

Romidepsin and total skin electron beam therapy in advanced stage mycosis fungoides and Sézary syndrome

Sonali M. Smith, S. Liauw, J. Kline, 2019, British journal of haematology.

A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)

Hao Wang, D. Song, P. Tran, 2019, BMC Cancer.

Role of HMG-CoA reductase inhibitors with curative radiotherapy in men with prostate cancer

S. Liauw, A. Solanki, 2011, Open access journal of urology.

Toxicity after external beam radiotherapy for prostate cancer: an analysis of late morbidity in men with diabetes mellitus.

S. Liauw, K. Kalakota, 2013, Urology.

External beam radiotherapy for prostate cancer: urinary outcomes for men with high International Prostate Symptom Scores (IPSS).

R. Malik, A. Jani, S. Liauw, 2011, International journal of radiation oncology, biology, physics.

Late rectal toxicity after prostate brachytherapy: influence of supplemental external beam radiation on dose-volume histogram analysis.

C. Pelizzari, A. Jani, S. Liauw, 2010, Brachytherapy.

Dose-escalated radiotherapy for high-risk prostate cancer: outcomes in modern era with short-term androgen deprivation therapy.

R. Weichselbaum, W. Stadler, A. Jani, 2009, International journal of radiation oncology, biology, physics.

Tobacco use and external beam radiation therapy for prostate cancer: Influence on biochemical control and late toxicity

S. Liauw, A. Solanki, 2013, Cancer.

Considering the role of radiation therapy for gastrointestinal stromal tumor

H. Kindler, S. Liauw, K. Corbin, 2014, OncoTargets and therapy.

Late toxicity after post-prostatectomy intensity modulated radiation therapy: Evaluating normal-tissue sparing guidelines

C. Pelizzari, A. Wong, S. Liauw, 2018, Advances in radiation oncology.

Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features

A. Niemierko, A. Zietman, M. Anscher, 2018, JAMA oncology.

Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate Cancer.

A. Zietman, M. Anscher, J. Hearn, 2017, European urology.

Long-term Outcome of Prostate Cancer Patients Who Exhibit Biochemical Failure Despite Salvage Radiation Therapy After Radical Prostatectomy

C. Roehrborn, Y. Lotan, Xian-Jin Xie, 2017, American journal of clinical oncology.

Managing Cancer Relapse After Radical Prostatectomy: Adjuvant Versus Salvage Radiation Therapy.

S. Eggener, S. Liauw, Joseph F. Rodriguez, 2017, The Urologic clinics of North America.

Bladder dose-volume parameters are associated with urinary incontinence after postoperative intensity modulated radiation therapy for prostate cancer.

C. Pelizzari, S. Eggener, J. Melotek, 2016, Practical radiation oncology.

A prospective trial of stereotactic body radiation therapy for unresectable pancreatic cancer testing ablative doses.

M. Posner, H. Kindler, S. Liauw, 2020, Journal of Gastrointestinal Oncology.

Pancreatic, Rectal, and Liver Cancers: Out With the Old, In With the New

James D. Murphy, J. Cheng, D. Chang, 2017 .

Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging.

C. Pelizzari, M. Vannier, A. Oto, 2013, International journal of radiation oncology, biology, physics.

The role of radiotherapy in locally advanced pancreatic carcinoma

R. Weichselbaum, S. Liauw, R. Gutt, 2010, Nature Reviews Gastroenterology &Hepatology.

Phase I Randomized Trial of Stereotactic Body Radiotherapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma.

Ashutosh Kumar Singh, S. Liauw, R. Iyer, 2022, International journal of radiation oncology, biology, physics.

Regional Influence of Radiation Oncology Residency Training on Job Securement over Two Time Periods

D. Golden, S. Liauw, J. Brower, 2019, Cureus.

Radiation dose ≥54 Gy and CA 19–9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation

D. Golden, B. Minsky, S. Liauw, 2012, Radiation oncology.

Executive Summary of the American Radium Society Appropriate Use Criteria for Radiation Treatment of Node-Negative Muscle Invasive Bladder Cancer.

A. Kishan, A. D'Amico, L. Potters, 2020, International journal of radiation oncology, biology, physics.

New Paradigms and Future Challenges in Radiation Oncology: An Update of Biological Targets and Technology

R. Weichselbaum, S. Liauw, Ralph R Weichselbaum, 2013, Science Translational Medicine.

Safety and Efficacy of Hypofractionated Radiotherapy With Capecitabine in Elderly Patients With Urothelial Carcinoma

N. Smith, P. O’Donnell, G. Steinberg, 2019, Clinical genitourinary cancer.

Intensity modulated radiation therapy after radical prostatectomy: Early results show no decline in urinary continence, gastrointestinal, or sexual quality of life.

S. Eggener, S. Liauw, K. Corbin, 2013, Practical radiation oncology.

Lymph Node-Positive Head and Neck Cancer Treated With Primary Radiotherapy: Can Treatment Response Determine the Extent of Neck Dissection?

W. Mendenhall, D. Villaret, R. Amdur, 2007 .

Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck.

W. Mendenhall, D. Villaret, R. Amdur, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Can Pre-treatment Quantitative Multi-parametric MRI Predict the Outcome of Radiotherapy in Patients with Prostate Cancer?

A. Oto, G. Karczmar, Xiaobing Fan, 2021, Academic radiology.

Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy.

Anthony V D'Amico, Janet E Cowan, A. D'Amico, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Aspirin Use and the Risk of Prostate Cancer Death in Men Treated with Prostatectomy or Radiotherapy: Results from the CaPSURE Database

A. D'Amico, P. Carroll, K. Choe, 2010 .

External beam radiotherapy for prostate cancer patients on anticoagulation therapy: how significant is the bleeding toxicity?

K. Choe, A. Jani, S. Liauw, 2010, International journal of radiation oncology, biology, physics.

The Effect of Intravenous Contrast on Intensity-Modulated Radiation Therapy Dose Calculations for Head and Neck Cancer

J. Palta, W. Mendenhall, Siyong Kim, 2005, American journal of clinical oncology.

Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.

J. Roeske, L. Mell, A. Mundt, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapy

Larissa V Furtado, N. Hyman, S. Xiao, 2018, PloS one.

Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.

J. Blasko, J. Sylvester, P. Grimm, 2006, International journal of radiation oncology, biology, physics.

Radiation oncology residency selection: A postgraduate evaluation of factor importance and survey of variables associated with job securement.

D. Golden, S. Liauw, J. Brower, 2017, Practical radiation oncology.

Comfort Level of US Radiation Oncology Graduates: Assessment of Transition to Independent Clinical Practice

D. Golden, S. Liauw, E. Gillespie, 2019, Journal of Cancer Education.

Application of a Prognostic Stratification System for High-risk Prostate Cancer to Patients Treated With Radiotherapy: Implications for Treatment Optimization

G. Merrick, P. McLaughlin, R. Dess, 2019, American journal of clinical oncology.

Radiotherapeutic Strategies in the Management of Low-Risk Prostate Cancer

K. Choe, S. Liauw, 2010, TheScientificWorldJournal.

ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II

Benjamin Movsas, Timothy N. Showalter, Anthony V. D'Amico, 2017, Advances in radiation oncology.

External beam radiation therapy after transurethral resection of the prostate: a report on acute and late genitourinary toxicity.

K. Zorn, A. Jani, S. Liauw, 2010, International journal of radiation oncology, biology, physics.

The use of Hormonal Therapy to Augment Radiation Therapy in Prostate Cancer: An Update

S. Liauw, Greg Kauffmann, 2017, Current Urology Reports.

Inflammatory breast carcinoma: Outcomes with trimodality therapy for nonmetastatic disease

S. Liauw, N. Mendenhall, C. Morris, 2004, Cancer.

Validation of normal tissue complication probability predictions in individual patient: late rectal toxicity.

C. Pelizzari, V. Semenenko, S. Tarima, 2013, International journal of radiation oncology, biology, physics.

Contemporary management of men with high-risk localized prostate cancer in the United States

J. Feinglass, E. Schaeffer, S. Eggener, 2017, Prostate Cancer and Prostatic Diseases.

18F-Fluciclovine positron emission tomography in men with biochemical recurrence of prostate cancer after radical prostatectomy and planning to undergo salvage radiotherapy: Results from LOCATE.

J. Tward, J. Michalski, N. Vapiwala, 2020, Practical radiation oncology.

Contemporary management of men with high-risk localized prostate cancer in the United States

J. Feinglass, E. Schaeffer, S. Eggener, 2017, Prostate Cancer and Prostatic Diseases.

External Validation and Optimization of International Consensus Clinical Target Volumes for Adjuvant Radiation Therapy in Bladder Cancer.

G. Steinberg, J. Christodouleas, S. Liauw, 2017, International journal of radiation oncology, biology, physics.

Patterns of Failure After Radical Cystectomy for pT3-4 Bladder Cancer: Implications for Adjuvant Radiation Therapy.

R. Weichselbaum, N. Smith, G. Steinberg, 2016, International journal of radiation oncology, biology, physics.

The perils of using registry data to compare the survival and cost of radical cystectomy and trimodality therapy in bladder cancer.

S. Liauw, A. Solanki, 2019, Translational andrology and urology.

In Reply to Zaghloul.

R. Weichselbaum, N. Smith, G. Steinberg, 2016, International journal of radiation oncology, biology, physics.

Modern Radiation Therapy and Cardiac Outcomes in Breast Cancer

R. Weichselbaum, N. Smith, G. Steinberg, 2016 .

Image-guided radiotherapy using surgical clips as fiducial markers after prostatectomy: a report of total setup error, required PTV expansion, and dosimetric implications.

Kamil M Yenice, K. Yenice, Małgorzata Kopeć, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer

A. D'Amico, G. Gustafson, P. McLaughlin, 2017, American journal of clinical oncology.

Improved outcomes after radiotherapy for prostate cancer: Anticoagulation, antiplatelet therapy, and platelet count as key factors in disease progression

K. Choe, S. Liauw, Jonathan L Miller, 2020, Cancer medicine.

ACR appropriateness criteria: Permanent source brachytherapy for prostate cancer.

A. D'Amico, G. Gustafson, P. McLaughlin, 2017, Brachytherapy.

PERMANENT SOURCE BRACHYTHERAPY FOR PROSTATE CANCER

A. D'Amico, G. Gustafson, P. McLaughlin, 2016 .

Isolated neck recurrence after definitive radiotherapy for node‐positive head and neck cancer: Salvage in the dissected or undissected neck

W. Mendenhall, D. Villaret, R. Amdur, 2007, Head & neck.

637P Biochemical response (PSA0) and testosterone (T) recovery in Metacure, a multi-arm multi-modality (MM) therapy (tx) for very high risk localized (HRL) and low volume metastatic (LVM) prostatic adenocarcinoma

J. Eastham, I. Kaplan, A. Kibel, 2021, Annals of Oncology.

A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer.

D. Kuban, C. Roehrborn, P. Scardino, 2005, Urology.

The clinical cell-cycle risk (CCR) score is associated with metastasis after radiation therapy and provides guidance on when to forgo combined androgen deprivation therapy with dose-escalated radiation.

J. Tward, C. Olsson, M. Brawer, 2021, International journal of radiation oncology, biology, physics.

A Surveillance, Epidemiology, and End Results Registry Analysis of Prostate Cancer Modality Time Trends by Age

P. Johnstone, P. Rossi, A. Jani, 2010, American journal of clinical oncology.

EXTERNAL BEAM RADIATION THERAPY TREATMENT PLANNING FOR CLINICALLY LOCALIZED PROSTATE CANCER

A. D'Amico, G. Gustafson, G. Ezzell, 2016 .

The impact of hormonal therapy on sexual quality of life in men receiving intensity modulated radiation therapy for prostate cancer.

S. Liauw, S. Chennupati, C. Son, 2015, Practical radiation oncology.

Prolongation of total treatment time because of infrequently missed days of treatment is not associated with inferior biochemical outcome after dose-escalated radiation therapy for prostate cancer.

S. Liauw, S. Liauw, 2011, International journal of radiation oncology, biology, physics.

A Contemporary Report of Low-Dose-Rate Brachytherapy for Prostate Cancer Using MRI for Risk Stratification: Disease Outcomes and Patient-Reported Quality of Life

A. Oto, S. Liauw, G. Zagaja, 2023, Cancers.

High-risk Prostate Cancer Treated with Radiation Therapy: Opportunities to Reduce Cancer Mortality after Biochemical Failure.

S. Liauw, 2021, European urology.

Goals of care discussions: perceptions of radiation and medical oncologists

D. Golden, S. Levine, S. Liauw, 2021, Supportive Care in Cancer.

Combined-modality Therapy for Rectal Cancer: Analysis of Potential Differences in Disease Presentation, Treatment Adherence, and Treatment Outcome According to Race

Julian C. Hong, D. Chang, B. Minsky, 2014, American journal of clinical oncology.

Clinical Outcomes for Gastric Cancer following Adjuvant Chemoradiation Utilizing Intensity Modulated versus Three-Dimensional Conformal Radiotherapy

E. Bair, M. Koshy, S. Liauw, 2014, PloS one.

Image-guided radiation therapy for prostate cancer: A computed tomography-based assessment of fiducial marker migration between placement and 7 days.

K. Yenice, C. Stepaniak, S. Liauw, 2015, Practical radiation oncology.

Considering the role of radiation therapy for gastrointestinal stromal tumor

H. Kindler, S. Liauw, K. Corbin, 2014 .

Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy

D. Chang, S. Liauw, A. Solanki, 2013, OncoTargets and therapy.

Role of HMG-CoA reductase inhibitors with curative radiotherapy in men with prostate cancer

S. Liauw, A. Solanki, 2011, Open access journal of urology.

D. Song, P. Tran, J. Hearn, 2019, BMC Cancer.

Patient-reported Outcomes and Late Toxicity After Postprostatectomy Intensity-modulated Radiation Therapy.

S. Eggener, S. Liauw, C. Liao, 2019, European urology.

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.

D. Kuban, M. Kattan, C. Roehrborn, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gastrointestinal Cancers: Timing Is Everything.

James D. Murphy, D. Chang, S. Apisarnthanarax, 2017 .

Unresectable Hepatocellular Carcinoma Due to Portal Venous Thrombosis: Focal Stereotactic Body Radiation Therapy Can Promote Resectability

M. Vannier, A. Y. Lee, S. Liauw, 2012, Journal of Gastrointestinal Cancer.

Statin use and risk of prostate cancer recurrence in men treated with radiation therapy.

R. Weichselbaum, T. Karrison, S. Liauw, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pretreatment multiparametric MRI is independently associated with biochemical outcome in men treated with radiation therapy for prostate cancer.

A. Oto, S. Liauw, P. Patel, 2018, Urologic oncology.

The use of capecitabine in the combined-modality therapy for rectal cancer.

B. Minsky, S. Liauw, 2008, Clinical colorectal cancer.

The use of anticoagulants improves biochemical control of localized prostate cancer treated with radiotherapy

K. Choe, A. Jani, S. Liauw, 2010, Cancer.

Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity modulated radiation therapy.

Srinivasan Vijayakumar, Diego R. Martín, Diego Martin, 2013, Practical radiation oncology.

A Surveillance, Epidemiology, and End Results Registry Analysis of Prostate Cancer Modality Time Trends by Age

P. Johnstone, P. Rossi, A. Jani, 2010, American journal of clinical oncology.

Hematologic Nadirs During Chemoradiation for Anal Cancer: Temporal Characterization and Dosimetric Predictors.

C. Pelizzari, D. Golden, D. Chang, 2017, International journal of radiation oncology, biology, physics.

Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy

M. Kattan, P. Scardino, M. Zelefsky, 2004 .

A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer.

D. Kuban, C. Roehrborn, P. Scardino, 2008, Urology.

EXTERNAL BEAM RADIATION THERAPY TREATMENT PLANNING FOR CLINICALLY LOCALIZED PROSTATE CANCER on Radiation Oncology–Prostate:

A. D'Amico, G. Gustafson, G. Ezzell, 2016 .

Dose-escalated radiotherapy for high-risk prostate cancer: outcomes in modern era with short-term androgen deprivation therapy.

R. Weichselbaum, W. Stadler, A. Jani, 2009, International journal of radiation oncology, biology, physics.

ACR appropriateness criteria: Permanent source brachytherapy for prostate cancer.

A. D'Amico, G. Gustafson, D. Assimos, 2017, Brachytherapy.

RENAL CELL CARCINOMA STAGING Expert Panel on Urologic Imaging: Raghunandan

M. Beland, M. Heilbrun, A. Purysko, 2019 .

Predicting the outcome of salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.

D. Kuban, M. Kattan, C. Roehrborn, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.